Separating sheep from goats: a European view on the patent eligibility of biomedical diagnostic methods

摘要

As is evident from Dan Burks?￠?? excellent paper 1 and critique, the Supreme Court's decisions in Mayo , Myriad and Alice and the CAFC's in Roslin 2 focused widespread attention on the formulation of patent-eligibility exclusions for specific biological ma